Caesarean section
Conditions
Interventions
Combined Intramuscular Pentazocine and Diclofenac.
bupivacaine wound infiltration and intramuscular diclofenac
Sponsors
PRIMARY RESEARCHER
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Pregnant women planned for elective caesarean section under spinal anaesthesia regardless of number of previous caesarean sections who consents to participate in the study after proper and appropriate counselling.
Exclusion criteria
Exclusion criteria: 1.Patients that are not able to understand or to use VAS(mentally retarded, psychiatric disorder) 2.Patient that undergoes caesarean section under general anaesthesia 3.Patients with proven or suspected allergy to local anaesthetics 4.Patients with proven or suspected allergy to Pentazocine or Diclofenac. 5.Patients chronically (more than 2 weeks) treated with Opioids medications. 6.Patients that are Opioids dependent or addicted ( determine by their previous experience with Opioids) 7.Patient with sickle cell disease or with uncontrollable diabetic mellitus. 8.Patients with chronic medical condition such as cardiovascular, hepatic or renal insufficiency 9.Booked pregnant women that did not consent 10.All emergencies or complicated caesarean sections such as obstructed labour, foetal distress, prolonged labour etc. 11.Patients with Intrauterine foetal death or Major foetal malformation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of Bupivacaine local wound infiltration and intramuscular Diclofenac with combined intramuscular Pentazocine and Diclofenac, as post caesarean section analgesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| . To compare rate of use of rescue analgesia between the study population and the control. | — |
Countries
Nigeria
Contacts
Public ContactAbubakar Danladi
Obstetrics and Gynaecology Department
Outcome results
None listed